HuGE Literature Finder
Records
1
-
11
| Genomic characterisation of hormone receptor-positive breast cancer arising in very young women. Annals of oncology : official journal of the European Society for Medical Oncology 2023 1 . Luen S J, Viale G, Nik-Zainal S, Savas P, Kammler R, Dell'Orto P, Biasi O, Degasperi A, Brown L C, Láng I, MacGrogan G, Tondini C, Bellet M, Villa F, Bernardo A, Ciruelos E, Karlsson P, Neven P, Climent M, Müller B, Joshum W, Bonnefoi H, Martino S, Davidson N E, Geyer C, Chia S K, Ingle J N, Coleman R, Solbach C, Thürlimann B, Colleoni M, Coates A S, Goldhirsch A, Fleming G F, Francis P A, Speed T P, Regan M M, Loi |
| ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 7 35 (12): 1804-1811. Grote Isabel, Bartels Stephan, Christgen Henriette, Radner Martin, Gronewold Malte, Kandt Leonie, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Graeser Monika, Kuemmel Sherko, Nitz Ulrike, Harbeck Nadia, Kreipe Hans, Christgen Matthi |
| Molecular differences between younger versus older ER-positive and HER2-negative breast cancers. NPJ breast cancer 2022 11 8 (1): 119. Qing Tao, Karn Thomas, Rozenblit Mariya, Foldi Julia, Marczyk Michal, Shan Naing Lin, Blenman Kim, Holtrich Uwe, Kalinsky Kevin, Meric-Bernstam Funda, Pusztai Laj |
| TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer medicine 2021 Nov . Grote Isabel, Bartels Stephan, Kandt Leonie, Bollmann Laura, Christgen Henriette, Gronewold Malte, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Nitz Ulrike, Kuemmel Sherko, Zu Eulenburg Christine, Braun Michael, Aktas Bahriye, Grischke Eva-Maria, Schumacher Claudia, Luedtke-Heckenkamp Kerstin, Kates Ronald, Wuerstlein Rachel, Graeser Monika, Harbeck Nadia, Christgen Matthias, Kreipe Ha |
| DNA damage response as a prognostic indicator in metastatic breast cancer via mutational analysis. Annals of translational medicine 2021 Feb 9 (3): 220. Rong Guohua, Yi Zongbi, Ma Fei, Guan Yanfang, Xu Yaping, Li Lifeng, Xu Bing |
| Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers. NPJ breast cancer 2018 4 19. Yap Yoon-Sim, Singh Angad P, Lim John H C, Ahn Jin-Hee, Jung Kyung-Hae, Kim Jeongeun, Dent Rebecca A, Ng Raymond C H, Kim Sung-Bae, Chiang Derek |
| Molecular features in young vs elderly breast cancer patients and the impacts on survival disparities by age at diagnosis. Cancer medicine 2018 5 7 (7): 3269-3277. Wang Mei-Xia, Ren Jun-Ting, Tang Lu-Ying, Ren Ze-Fa |
| Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer. JCO precision oncology 2018 2018 . Meric-Bernstam Funda, Zheng Xiaofeng, Shariati Maryam, Damodaran Senthil, Wathoo Chetna, Brusco Lauren, Demirhan Mehmet Esat, Tapia Coya, Eterovic Agda Karina, Basho Reva K, Ueno Naoto T, Janku Filip, Sahin Aysegul, Rodon Jordi, Broaddus Russell, Kim Tae-Beom, Mendelsohn John, Mills Shaw Kenna R, Tripathy Debu, Mills Gordon B, Chen K |
| Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Sep . Lavigne Marion, Menet Emmanuelle, Tille Jean-Christophe, Lae Marick, Fuhrmann Laetitia, Bonneau Claire, Deniziaut Gabrielle, Melaabi Samia, Ng Charlotte C K, Marchiò Caterina, Rouzier Roman, Bièche Ivan, Vincent-Salomon An |
| Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Mar . Pang Jia-Min B, Savas Peter, Fellowes Andrew P, Mir Arnau Gisela, Kader Tanjina, Vedururu Ravikiran, Hewitt Chelsee, Takano Elena A, Byrne David J, Choong David Yh, Millar Ewan Ka, Lee C Soon, O'Toole Sandra A, Lakhani Sunil R, Cummings Margaret C, Mann G Bruce, Campbell Ian G, Dobrovic Alexander, Loi Sherene, Gorringe Kylie L, Fox Stephen |
| GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma. Oncology reports 2014 2 31 (4): 1523-30. Peters Inga, Gebauer Kai, Dubrowinskaja Natalia, Atschekzei Faranaz, Kramer Mario W, Hennenlotter Joerg, Tezval Hossein, Abbas Mahmoud, Scherer Ralph, Merseburger Axel S, Stenzl Arnulf, Kuczyk Markus A, Serth Juerg |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 21, 2023
- Content source: